Abstract:Influenza D virus (IDV) of the Orthomyxoviridae family has a wide host range and a broad geographical distribution. Recent IDV outbreaks in swine along with serological and genetic evidence of IDV infection in humans have raised concerns regarding the zoonotic potential of this virus. To better study IDV at the molecular level, a reverse-genetics system (RGS) is urgently needed, but to date, no RGS had been described for IDV. In this study, we rescued the recombinant influenza D/swine/Oklahoma/1314/2011 (D/OK) virus by using a bidirectional seven-plasmid-based system and further characterized rescued viruses in terms of growth kinetics, replication stability, and receptor-binding capacity. Our results collectively demonstrated that RGS-derived viruses resembled the parental viruses for these properties, thereby supporting the utility of this RGS to study IDV infection biology. In addition, we developed an IDV minigenome replication assay and identified the E697K mutation in PB1 and the L462F mutation in PB2 that directly affected the activity of the IDV ribonucleoprotein (RNP) complex, resulting in either attenuated or replication-incompetent viruses. Finally, by using the minigenome replication assay, we demonstrated that a single nucleotide polymorphism at position 5 of the 3' conserved noncoding region in IDV and influenza C virus (ICV) resulted in the inefficient cross-recognition of the heterotypic promoter by the viral RNP complex. In conclusion, we successfully developed a minigenome replication assay and a robust reverse-genetics system that can be used to further study replication, tropism, and pathogenesis of IDV.IMPORTANCE Influenza D virus (IDV) is a new type of influenza virus that uses cattle as the primary reservoir and infects multiple agricultural animals. Increased outbreaks in pigs and serological and genetic evidence of human infection have raised concerns about potential IDV adaptation in humans. Here, we have developed a plasmid-based IDV reverse-genetics system that can generate infectious viruses with replication kinetics similar to those of wild-type viruses following transfection of cultured cells. Further characterization demonstrated that viruses rescued from the described RGS resembled the parental viruses in biological and receptor-binding properties. We also developed and validated an IDV minireplicon reporter system that specifically measures viral RNA polymerase activity. In summary, the reverse-genetics system and minireplicon reporter assay described in this study should be of value in identifying viral determinants of cross-species transmission and pathogenicity of novel influenza D viruses.

In vitro one-pot construction of influenza viral genomes for virus particle synthesis based on reverse genetics system

The Reverse Genetics Systems for Human and Animal RNA Viruses

Rapid Construction of Complex Plant RNA Virus Infectious Cdna Clones for Agroinfection Using a Yeast-E. Coli-Agrobacterium Shuttle Vector

Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics

Replication-competent influenza virus with a protein-responsive multiplication ability

One-pot Golden Gate Assembly of an avian infectious bronchitis virus reverse genetics system

High-throughput investigation of genetic design constraints in domesticated Influenza A Virus for transient gene delivery

Defining the minimal components of the influenza A virus replication machinery via an in vitro reconstitution system

A rapid and versatile reverse genetics approach for generating recombinant positive-strand RNA viruses that use IRES-mediated translation

Development and Characterization of a Reverse-Genetics System for Influenza D Virus

A cell-based screening system for influenza A viral RNA transcription/replication inhibitors

Reverse genetics plasmid for cloning unstable influenza A virus gene segments.

Synthetic Cell Lines for Inducible Packaging of Influenza A Virus

Establishment of a High-Throughput Assay to Monitor Influenza A Virus RNA Transcription and Replication

Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.

Construction of an infectious clone for enterovirus A89 and mutagenesis analysis of viral infection and cell binding

Entirely plasmid-based reverse genetics system for rotaviruses

Generation of infectious pancreatic necrosis virus from cloned cDNA

Infectious subgenomic amplicon strategies for Japanese encephalitis and West Nile viruses

Neuroprotective and Cytotoxic Phthalides from Angelicae Sinensis Radix

Conformational Dynamics of Influenza A Virus Ribonucleoprotein Complexes during RNA Synthesis